|ChineseInvestors.com (CIIX) Successfully Incubates Spinoff|
- Multifaceted international company, first and only to offer hemp-infused skin care products in China
- Now set to spin off new subsidiaries
- Shareholders likely to benefit from value-add transaction
In business for nearly two decades, ChineseInvestors.com (OTCQB: CIIX) began as a specialized investment services company providing real-time commentary, analysis and education-related services in the Chinese language. While building recurring revenues through its unique 100,000+ user base, CIIX maintained a long term vision for value-add opportunities. In 2016, the company identified one of the fastest growing markets in the world and entered the explosive new medical CBD market. Targeting the nearly two billion Chinese-speaking people worldwide, ChineseInvestors.com launched into online sales of CBD products and continued to expand its core investor education business, adding a daily video telecast on cryptocurrencies aimed at Chinese speakers.
Initially, forays into the Chinese CBD market focused on global online sales of oils through subsidiary ChineseCBDoil.com. As CIIX gained traction and established a significant footprint in the global CBD market, it then opened a huge untapped market by becoming the first and only known company to offer hemp-infused skin care products in China. The company retails its hemp oil-based cannabidiol (CBD) products on Alibaba and Amazon under the “OptHemp” brand through its wholly-owned subsidiaries, CBD Biotechnology Co. Ltd. and ChineseHempOil.com, Inc.
CIIX’s CBD endeavors have proved so successful that the company just announced plans to spin off its wholly-owned foreign enterprise, CBD Biotechnology Co. Ltd., and its wholly-owned subsidiary, ChineseHempOil.com, Inc. in order to transition the subsidiary from a private startup to a successful public company (http://nnw.fm/FNpC4). Spinning off these entities will allow CIIX to focus on its cryptocurrency division and core financial education business.
ChineseInvestor.com CEO Warren Wang, in a news release, said “We are excited to announce our intention to spin off CBD Biotechnology and ChineseHempOil.com, Inc. as we believe the existing business lines and the new acquisitions in China, secured by CEO Summer Yun, will allow these entities to continue to grow in their respective markets, while bringing new value to the company’s existing shareholders. The details about the value to the company’s existing shareholders will be announced in the coming weeks.”
CIIX has managed to incubate a high growth company and has intentions of listing the shares of the subsidiary’s common stock for trading on the OTCQB. This initiative should bode exceptionally well for existing shareholders as the realized value of the transaction becomes more apparent. CIIX will now return focus to its core financial education business and its new cryptocurrency division. With its track record of identifying and seizing upon growth opportunities, it wouldn’t be surprising to see CIIX repeat another successful spinoff.
For more information, visit the company’s website at www.ChineseInvestors.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer